Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Series-B

News NEURA Robotics secures 120 million euros The EUR 120 million Series B financing is intended to enable further groundbreaking products and the expansion of the "Neuraverse" ecosystem.

Marc Nemitz 16.01.2025

News 50 million euros for Berlin fintech Nelly Digitalization in the healthcare sector - Nelly continues to scale. The start-up is planning product enhancements and international expansion. Over 1,200 medical practices already use the system

Marc Nemitz 15.01.2025

News 25 million dollars for NatureMetrics New capital for biodiversity innovation: NatureMetrics takes nature reporting to the next level and drives digital solutions for sustainable businesses.

Marc Nemitz 14.01.2025

News Embotech successful with CHF 23.5 million Series B Thanks to new investments, Embotech is driving forward the automation of vehicle and port logistics. With BMW i Ventures as a partner, new solutions are being rolled out worldwide.

Marc Nemitz 17.12.2024

News 26 million US dollars in Series B for AMPECO AMPECO secures fresh capital for global EV charging networks! AMPECO is driving the future of electric mobility with new financing and an innovative platform.

Marc Nemitz 26.11.2024

News The Exploration Company closes 150 million euro Series B round The Exploration Company closes largest Series B round in the European space industry to develop the first European reusable space capsule Nyx and strengthen Europe's sovereignty in space.

Marc Nemitz 18.11.2024

News Bounce secures 19 million US dollars in Series B Bounce receives USD 19 million in Series B funding for the global expansion of its luggage storage network. The startup plans to expand its offering in Germany and other countries.

Marc Nemitz 14.11.2024

News SynOx Therapeutics increases capital to USD 92 million in Series B financing Gilde Healthcare leads Series B extension and supports Phase 3 TANGENT study for emactuzumab, a promising CSF-1R-targeted therapy for tenosynovial giant cell tumor

Marc Nemitz 30.10.2024

News Aignostics secures 34 million US dollars in Series B Aignostics strengthens precision medicine through AI-based pathology models. The funds will be used for new products, US expansion and collaboration with the Mayo Clinic.

Marc Nemitz 29.10.2024

News AvenCell secures USD 112 million in Series B funding AvenCell plans to use USD 112 million in funding to further develop its switchable CAR-T cell therapy platform. The goal: safer and more flexible treatments for cancer and autoimmune diseases.

Marc Nemitz 23.10.2024

1
2
3
4